[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100620273":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":33,"responsibleParty":76,"collaborators":10,"id":78,"slug":79,"hasResults":80,"nctId":81,"briefTitle":82,"officialTitle":82,"acronym":10,"eligibilityCriteria":83,"healthyVolunteers":80,"sex":84,"minAge":85,"maxAge":10,"enrollmentInfo":86,"targetDuration":89,"studyType":90,"phases":10,"briefSummary":91,"conditions":92,"keywords":94,"overallStatus":96,"whyStopped":10,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":106},{"fullName":5,"class":6},"Bristol-Myers Squibb","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Group 1",null,"Participants diagnosed with myelodysplastic syndromes (MDS)",[13],"Drug: Prescribed treatments for myelodysplastic syndromes (MDS)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DRUG","Prescribed treatments for myelodysplastic syndromes (MDS)","According to the product label",[9],[21,24],{"name":22,"affiliation":5,"role":23},"Bristol Myers Squibb","STUDY_DIRECTOR",{"name":5,"affiliation":5,"role":23},[26,31],{"name":27,"role":28,"phone":29,"phoneExt":10,"email":30},"BMS Clinical Trials Contact Center www.BMSClinicalTrials.com","CONTACT","855-907-3286","Clinical.Trials@bms.com",{"name":32,"role":28,"phone":10,"phoneExt":10,"email":10},"First line of the email MUST contain NCT # and Site #.",[34,48,62],{"facility":35,"status":10,"city":36,"state":10,"zip":37,"country":36,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Local Institution - 0003","Singapore","169608","SG",{"type":40,"coordinates":41},"Point",[42,43],103.85007,1.28967,{"lat":43,"lon":42},[46],{"name":47,"role":28,"phone":10,"phoneExt":10,"email":10},"Site 0003",{"facility":49,"status":10,"city":50,"state":51,"zip":52,"country":53,"countryCode":10,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"Local Institution - 002","Seoul","Seoul Teugbyeolsi","03080","South Korea",{"type":40,"coordinates":55},[56,57],126.9784,37.566,{"lat":57,"lon":56},[60],{"name":61,"role":28,"phone":10,"phoneExt":10,"email":10},"Site 002",{"facility":63,"status":10,"city":64,"state":10,"zip":65,"country":66,"countryCode":67,"cosmosGeoPoint":68,"geoPoint":72,"contacts":73},"Local Institution - 0001","Taipei","100229","Taiwan","TW",{"type":40,"coordinates":69},[70,71],121.52639,25.05306,{"lat":71,"lon":70},[74],{"name":75,"role":28,"phone":10,"phoneExt":10,"email":10},"Site 0001",{"type":77,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100620273","asia-myelodysplastic-syndrome-mds-registry-100620273",false,"NCT07355478","Asia Myelodysplastic Syndrome (MDS) Registry","Inclusion Criteria:\n\nRetrospective enrolment of Myelodysplastic Syndrome (MDS) participants:\n\n* Aged at least 18 years at initial diagnosis of MDS\n* Diagnosed with MDS according to World Health Organization (WHO) 2008, WHO 2016, or WHO 2022 criteria between 1 January 2019 and 31 December 2022; and\n* Diagnosed with MDS within 100 days from the date of diagnostic bone marrow (BM) aspirate\n\nInclusion criteria for the prospective enrolment of MDS participants:\n\n* Aged at least 18 years at initial diagnosis of MDS; and\n* Diagnosed with MDS according to World Health Organization (WHO) 2008, WHO 2016, or WHO 2022 criteria between 1 October 2025 and 30 September 2026; and\n* Diagnosed with MDS within 100 days from the date of diagnostic BM aspirate\n\nExclusion Criteria:\n\n• None","ALL","18 Years",{"count":87,"type":88},500,"ESTIMATED","2 Years","OBSERVATIONAL","The purpose of this study is to provide a contemporary view and offer invaluable insights into the demographic profiles, clinical characteristics, treatments, and real-world outcomes of individuals with myelodysplastic syndromes (MDS) in Asia.",[93],"Myelodysplastic Syndromes (MDS)",[95],"Myelodysplastic syndromes (MDS)","NOT_YET_RECRUITING","2026-02-12",{"date":99,"type":100},"2026-02-13","ACTUAL",{"date":102,"type":88},"2026-03-26",{"date":104,"type":88},"2027-09-30",{"name":5,"class":6},3]